Home・Listă Acțiuni・OPKO Health Inc

OPKO Health Inc

Închisă

SectorSănătate

1.64 2.5

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

1.63

Maxim

1.6400000000000001

Indicatori cheie
By Trading Economics
Venit	46M -8.4M
Vânzări	39M 164M
EPS	-0.01
Marjă de profit	-5.145
Angajați	2,275
EBITDA	40M 12M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+82.93% upside

Dividende
By Acuity
Următoarele câștiguri	28 oct. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	191M 1.1B
Deschiderea anterioară	-0.86
Închiderea anterioară	1.64

Sentimentul știrilor

By Acuity

61%

39%

276 / 339 Clasament în Healthcare

OPKO Health Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 sept. 2026, 20:07 UTC

OPKO Health Inc. shares are higher today, rebounding significantly after an initial dip and currently 12.75% above the 20-day moving average.

3 sept. 2026, 21:02 UTC

OPKO Health Inc. is higher in after-hours trading, reflecting gains since Thursday's close amid declining Treasury yields and improved investor sentiment.

2 sept. 2026, 23:46 UTC

OPKO Health Inc. shares were roughly flat during after-market hours, maintaining a significant one-month increase of about 29%.

1 sept. 2026, 20:01 UTC

OPKO Health shares are higher today, remaining above their 20-day moving average amid rising oil prices and inflation concerns affecting the broader market.

28 aug. 2026, 19:16 UTC

OPKO Health Inc. shares are lower today, having reached a session low. The stock remains within its one-month trading range and above the 20-day moving average.

27 aug. 2026, 23:01 UTC

OPKO Health Inc. shares are higher in after-market trading, reflecting strong performance since Thursday's close and maintaining a position above its 20-day moving average.

26 aug. 2026, 20:08 UTC

OPKO Health Inc shares are higher during Wednesday's session, maintaining a position above the 20-day moving average amid mixed broader market performance.

25 aug. 2026, 19:36 UTC

OPKO Health Inc. shares are higher today, remaining above their 20-day moving average despite earlier fluctuations during the session.

24 aug. 2026, 22:01 UTC

OPKO Health Inc. shares are lower in after-market trading, reflecting a shift in momentum since Monday's close. The stock remains above its 20-day moving average.

21 aug. 2026, 23:56 UTC

OPKO Health Inc. shares declined in after-market trading, despite gains in major stocks as the broader market rebounded from earlier pressures.

20 aug. 2026, 19:56 UTC

OPKO Health Inc. shares are higher today, maintaining a position above their 20-day moving average amid no specific company news identified.

19 aug. 2026, 20:02 UTC

OPKO Health Inc shares are higher in Wednesday's session, recovering from an early dip. The stock remains above its 20-day moving average.

18 aug. 2026, 19:16 UTC

OPKO Health Inc shares are lower amid broader market declines, influenced by rising Treasury yields and inflation concerns following a significant drop in housing starts.

17 aug. 2026, 19:06 UTC

News

OPKO Health Inc. shares are lower today, continuing a decline since Friday. The company issued $125 million in senior secured notes linked to mazdutide royalties.

14 aug. 2026, 19:36 UTC

OPKO Health Inc shares are lower amid broader market concerns following a reported decline in retail sales for July. The stock reached a session low earlier.

13 aug. 2026, 23:01 UTC

OPKO Health shares lower in after-market trading, declining since Thursday's close amid mixed macroeconomic signals and uncertainty in the market.

12 aug. 2026, 19:36 UTC

OPKO Health Inc shares are modestly higher, reflecting a positive market environment amid recent risk asset gains. Core CPI data aligns with forecasts, supporting steady interest rates.

11 aug. 2026, 19:36 UTC

OPKO Health Inc shares are higher, maintaining a position above their 20-day moving average amid broader market sentiment influenced by geopolitical tensions and inflation reports.

10 aug. 2026, 19:46 UTC

OPKO Health Inc. shares are trading higher amid broader market uncertainty, reflecting notable strength above its 20-day moving average since Friday's close.

7 aug. 2026, 23:01 UTC

OPKO Health shares advanced in after-market trading, recovering from earlier losses amid broader market dynamics and a slight decline in the unemployment rate.

6 aug. 2026, 19:16 UTC

OPKO Health Inc. shares are lower today amid notable volatility, with economic data showing initial jobless claims rose slightly ahead of tomorrow's non-farm payrolls report.

5 aug. 2026, 23:01 UTC

OPKO Health shares are lower in after-market hours, reflecting broader market weakness amid recent economic data showing weaker-than-expected U.S. job growth.

4 aug. 2026, 23:06 UTC

OPKO Health Inc. shares are higher in after-market trading, settling with a cumulative gain following a brief dip at the session's start.

3 aug. 2026, 23:01 UTC

OPKO Health Inc shares increased in after-market trading, maintaining a steady rise since Monday's close amid a generally positive market backdrop.

31 iul. 2026, 19:45 UTC

OPKO Health Inc. shares are trading roughly flat today, hovering around the middle of their one-month range and above the 20-day moving average.

30 iul. 2026, 23:11 UTC

OPKO Health Inc. shares are lower in after-market hours, continuing a recent trend amid broader market uncertainty following the Federal Reserve's interest rate decision.

29 iul. 2026, 23:46 UTC

No specific news was identified for OPKO Health Inc. Shares remained roughly flat during after-market hours, trading near unchanged since Wednesday's close.

28 iul. 2026, 23:41 UTC

News

OPKO Health reported a narrowed net loss of $8.4 million and raised revenue guidance, but shares are lower in after-market hours following recent gains.

27 iul. 2026, 23:41 UTC

News

OPKO Health reported second-quarter revenues of $163.5 million, surpassing expectations. The company also raised its full-year sales guidance, boosting shares in after-market trading.

24 iul. 2026, 22:06 UTC

OPKO Health Inc shares are higher in after-market trading, reaching a peak shortly after the market closed. No specific news was identified for this movement.

Comparație

Modificare preț

OPKO Health Inc Așteptări

Obiectiv de preț

By TipRanks

82.93% sus

Prognoză pe 12 luni

Medie 3 USD 82.93%

Maxim 3 USD

Minim 3 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOPKO Health Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

3 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 3 analiști care au acordat evaluări ale acțiunilor OPKO Health Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

276 / 339 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.